NDC 51715-100

XARACOLL

Bupivacaine Hcl Collagen-matrix

XARACOLL is a Parenteral Implant in the Human Prescription Drug category. It is labeled and distributed by Innocoll Pharmaceuticals. The primary component is Bupivacaine.

Product ID51715-100_23477215-fcfc-4b11-a5c3-b2034c31aefb
NDC51715-100
Product TypeHuman Prescription Drug
Proprietary NameXARACOLL
Generic NameBupivacaine Hcl Collagen-matrix
Dosage FormImplant
Route of AdministrationPARENTERAL
Marketing Start Date2020-08-28
Marketing CategoryNDA / NDA
Application NumberNDA209511
Labeler NameINNOCOLL PHARMACEUTICALS
Substance NameBUPIVACAINE
Active Ingredient Strength100 mg/1
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51715-100-04

4 CARTON in 1 CARTON (51715-100-04) > 1 POUCH in 1 CARTON > 3 IMPLANT in 1 POUCH
Marketing Start Date2020-08-28
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [XARACOLL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
XARACOLL
XARACOLL
90738266 not registered Live/Pending
Innocoll Pharmaceuticals Limited
2021-05-27
XARACOLL
XARACOLL
88806837 not registered Live/Pending
Innocoll Pharmaceuticals Limited
2020-02-22
XARACOLL
XARACOLL
87724683 not registered Live/Pending
Innocoll Pharmaceuticals Limited
2017-12-18
XARACOLL
XARACOLL
85080255 4092973 Dead/Cancelled
Innocoll Pharmaceuticals Limited
2010-07-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.